<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>47(1)</volume><submitter>Hanaa S Mohamed</submitter><pubmed_abstract>The present study aimed to synthesis &lt;i>N&lt;/i>-substituted-5-(4-chloroquinolin-2-yl)-1,3,4-thiadiazol-2-amine derivatives. Molecular docking study of the synthesized compounds was carried out. COVID-19 docked with the synthesized compounds and the results indicated that the binding energies of docking 6LU7 with native ligand, and the synthesized compounds were -8.1, -8.0, -7.7, -7.5, -7.4, -7.3, -7.2, -6.7, -6.6, -6.5, and -5.4 kcal/mol.&lt;h4>Supplementary information&lt;/h4>The online version contains supplementary material available at 10.1134/S1068162021010155.</pubmed_abstract><journal>Russian journal of bioorganic chemistry</journal><pagination>158-165</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7980798</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Synthesis, Molecular Docking, In Silico ADME Predictions, and Toxicity Studies of &lt;i>N&lt;/i>-Substituted-5-(4-Chloroquinolin-2-yl)-1,3,4-Thiadiazol-2-Amine Derivatives as COVID-19 Inhibitors.</pubmed_title><pmcid>PMC7980798</pmcid><pubmed_authors>Hanaa S Mohamed</pubmed_authors><pubmed_authors>El-Serwy WS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis, Molecular Docking, In Silico ADME Predictions, and Toxicity Studies of &lt;i>N&lt;/i>-Substituted-5-(4-Chloroquinolin-2-yl)-1,3,4-Thiadiazol-2-Amine Derivatives as COVID-19 Inhibitors.</name><description>The present study aimed to synthesis &lt;i>N&lt;/i>-substituted-5-(4-chloroquinolin-2-yl)-1,3,4-thiadiazol-2-amine derivatives. Molecular docking study of the synthesized compounds was carried out. COVID-19 docked with the synthesized compounds and the results indicated that the binding energies of docking 6LU7 with native ligand, and the synthesized compounds were -8.1, -8.0, -7.7, -7.5, -7.4, -7.3, -7.2, -6.7, -6.6, -6.5, and -5.4 kcal/mol.&lt;h4>Supplementary information&lt;/h4>The online version contains supplementary material available at 10.1134/S1068162021010155.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-05-03T09:27:51.853Z</modification><creation>2022-02-09T10:18:03.611Z</creation></dates><accession>S-EPMC7980798</accession><cross_references><pubmed>33776395</pubmed><doi>10.1134/S1068162021010155</doi></cross_references></HashMap>